| STAT5A and STAT5B—twins with different personalities in hematopoiesis and leukemia B Maurer, S Kollmann, J Pickem, A Hoelbl-Kovacic, V Sexl Cancers 11 (11), 1726, 2019 | 67 | 2019 |
| CDK6 antagonizes p53-induced responses during tumorigenesis F Bellutti, AS Tigan, S Nebenfuehr, M Dolezal, M Zojer, R Grausenburger, ... Cancer discovery 8 (7), 884-897, 2018 | 67 | 2018 |
| Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia S Kollmann, E Grundschober, B Maurer, W Warsch, R Grausenburger, ... Leukemia 33 (7), 1583-1597, 2019 | 56 | 2019 |
| A STAT5B–CD9 axis determines self-renewal in hematopoietic and leukemic stem cells S Kollmann, R Grausenburger, T Klampfl, M Prchal-Murphy, K Bastl, ... Blood, The Journal of the American Society of Hematology 138 (23), 2347-2359, 2021 | 36 | 2021 |
| Inducible deletion of CDK4 and CDK6–deciphering CDK4/6 inhibitor effects in the hematopoietic system B Maurer, T Brandstoetter, S Kollmann, V Sexl, M Prchal-Murphy Haematologica 106 (10), 2624, 2021 | 18 | 2021 |
| PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma I Garces de los Fayos Alonso, L Zujo, I Wiest, P Kodajova, G Timelthaler, ... Molecular Cancer 21 (1), 172, 2022 | 8 | 2022 |
| A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia K Klein, S Kollmann, A Hiesinger, J List, J Kendler, T Klampfl, ... Blood 143 (24), 2474-2489, 2024 | 2 | 2024 |
| Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells IM Mayer, E Doma, T Klampfl, M Prchal-Murphy, S Kollmann, A Schirripa, ... Blood 144 (2), 156-170, 2024 | 1 | 2024 |
| SBNO2 is a critical mediator of STAT3-driven hematological malignancies T Brandstoetter, J Schmoellerl, R Grausenburger, S Kollmann, E Doma, ... Blood 141 (15), 1831-1845, 2023 | 1 | 2023 |
| S227: SBNO2 IS A SPECIFIC DEPENDENCY OF STAT3-DRIVEN T-CELL MALIGNANCIES T Brandstoetter, B Maurer, J Schmoellerl, S Kollmann, J Huuhtanen, ... HemaSphere 6, 128-129, 2022 | 1 | 2022 |
| STAT1 and MHCII: guardians of stressed HSCs S Kollmann, V Sexl Blood, The Journal of the American Society of Hematology 140 (14), 1575-1576, 2022 | | 2022 |
| CDK6 antagonizes p53-induced responses during tumorigenesis. Cancer Discov. 2018; 8: 884–897. doi: 10.1158/2159-8290 F Bellutti, AS Tigan, S Nebenfuehr, M Dolezal, M Zojer, R Grausenburger, ... CD-17-0912.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | | |
